In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Acclarent: Can Balloons Open Sinuses and the ENT Device Market?

Executive Summary

Acclarent is developing interventional technology for the sinuses, targeting a clinical specialty unfamiliar with these techniques, in the hope of expanding an under-served device area. But will ENT surgeons welcome the change?
Advertisement

Related Content

Entellus: Helping The Interventional Revolution Balloon In Sinus Therapy
In Medical Devices, Is "Good Enough" Good Enough?
Ethicon Buys Acclarent: Can This Exit Open Up ENT?
Device Innovations Target ENT
Medtech Investing 2009: What's Changed?
Market & Industry Briefs
Endoscopic Procedures Nose Up in ENT Market
Medical Device and In Vitro Diagnostics/Research Deal Statistics Quarterly, Q2 2008
Institutional Innovation in Devices
Xomed: Nosing out a Niche in ENT

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV002655

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel